Image
  • Consulting
  • M&A Analysis
  • Insurance Policy Review
  • News
  • Who We Are
  • Contact Us

FDA cited Akorn’s New Jersey plant even as drugmaker fought Fresenius in court over abandoned buyout

Recent Posts

  • 130 Attend NHIA Talk Infusion Webinar on Compliance and Risk Considerations for Compounding Pharmacies
  • Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing Facilities
  • FDA cited Akorn’s New Jersey plant even as drugmaker fought Fresenius in court over abandoned buyout

Categories

  • Industry News
Image
© 2022
  • Consulting
  • M&A Analysis
  • Insurance Policy Review
  • News
  • Who We Are
  • Contact Us